Stroke, not specified as haemorrhage or infarction
Conditions
Interventions
Experimental group: 10 post-stroke individuals with plantar flexor muscles spasticity, will be submitted of Botulinum Toxin Type A application on plantar flexor muscles, associated with a physiotherap
H02.010.625
Sponsors
Laboratório de Pesquisa do Exercício, Universidade Federal do Rio Grande do Sul
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Diagnosis of ischemic or hemorrhagic stroke; incident time greater than 12 months; age equal or superior to 20 years; ability to walk with or without crutches; presence of spasticity in the ankle plantiflexor muscles.
Exclusion criteria
Exclusion criteria: Do not use BTX-A for a minimum of 6 months; not be performing physiotherapy; history of surgical procedure or use of orthopedic prosthesis; use of orthoses; cardiovascular and respiratory impairment limiting physical exertion; presence of progressive or insane neurological disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle strength increased, verified by isokinetic dynamometry, with a variation of at least 5% in pre and post-intervention measurements.;Functional performance improvement, verified by the tests: eight-meter brisk walk, Timed Up and Go and Sit-to-Stand, with a variation of at least 5% in pre and post-intervention measurements.;Muscle architecture improvement, verified by ultrasound, with a variation of at least 5% in pre and post-intervention measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| Flexibility Increased, verified through goniometry, with a variation of at least 5% in pre and post-intervention measurements.;Spasticity reduction, verified by the Ashworth Modified Scale, with a variation of at least 5% in the pre and post intervention measurements. | — |
Countries
Brazil
Contacts
Public ContactCaroline Dias
Laboratório de Pesquisa do Exercício, Universidade Federal do Rio Grande do Sul
Outcome results
None listed